EDGAR Filing Documents for 0001564590-20-029180

Form 8-K - Current report:

SEC Accession No. 0001564590-20-029180

Filing Date

2020-06-12

Accepted

2020-06-12 16:28:33

Documents

Period of Report

2020-06-11

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	crsp-8k_20200611.htm iXBRL	8-K	329370
2	EX-3.1	crsp-ex31_6.htm	EX-3.1	382278
	Complete submission text file	0001564590-20-029180.txt		912824

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA	crsp-20200611.xsd	EX-101.SCH	5776
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE	crsp-20200611_lab.xml	EX-101.LAB	19400
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	crsp-20200611_pre.xml	EX-101.PRE	11603
11	EXTRACTED XBRL INSTANCE DOCUMENT	crsp-8k_20200611_htm.xml	XML	3529

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300

Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600

CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)